NNNikos Nikolopoulos

Nikos Nikolopoulos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nikos Nikolopoulos has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Yorgo Modis

    Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK

    2 shared publications
  • Christophe Grangeasse

    Molecular Microbiology and Structural Biochemistry, CNRS UMR 5086, Université Claude Bernard Lyon 1, Lyon, France

    1 shared publication
  • Daniil M. Prigozhin

    Berkeley Center for Structural Biology, Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA

    1 shared publication
  • François Leulier

    Institut de Génomique Fonctionnelle de Lyon, École Normale Supérieure de Lyon, CNRS UMR 5242, Lyon 1 Université Claude Bernard, Lyon, France

    1 shared publication
  • Hiroto Hirayama

    Institute for Glyco-Core Research (iGCORE), Gifu University, Gifu, Japan; GlycoMIRAI, CNRS, IRL 2045, Nagoya University, Nagoya, Japan

    1 shared publication
  • Jean-Pierre Simorre

    Institut de Biologie Structurale, Université Grenoble Alpes, CEA, CNRS UMR 5075, 3800, Grenoble, France

    1 shared publication

Latest Publications

  • Open Access

    A DltE–DltD–DltX interaction network regulates lipoteichoic acid D-alanylation and Lactiplantibacillus plantarum-mediated growth promotion in Drosophila

    by Renata C. Matos, Nikos Nikolopoulos, Quentin Perrier, Xavier Robert, Virginie Gueguen-Chaignon, Hiroto Hirayama, Jean-Pierre Simorre, François Leulier, Christophe Grangeasse, Yann Guerardel, et al.

  • Open Access

    Crystal structure of HERV-K envelope glycoprotein surface subunit

    by Nikos Nikolopoulos, Yorgo Modis

    The most recently acquired and transcriptionally active family of human endogenous retroviruses (HERVs) is HERV-K. Of the approximately 100 copies of HERV-K in our genome, many retain the potential to proliferate by retrotransposition, express viral proteins, and form functional virus particles. Aberrant expression of the HERV-K envelope glycoprotein (Env) has been associated with cancer and neurodegeneration. Autoantibodies against HERV-K Env have been found in patients with various autoimmune diseases. Here, we report the crystal structures of the Env surface subunit (SU) from HERV-K HML-2, determined at 2.25 Å resolution. The overall fold is somewhat similar to Syncycin-2 SU and distantly related to HIV-1 gp120. The structure contains five disulfide bonds and four N-linked glycans, including one glycan that appears important for structural stability. Two extended loops form a surface for potential interactions with cell-surface receptors or other cellular factors. The structure also contains three detergent molecules, similar in structure to cholesterol, bound to hydrophobic surface patches. This crystal structure provides a platform for future studies to map autoantigenic epitopes, identify small-molecules that interfere with HERV-K activity, and extend our mechanistic understanding of retroviruses. IMPORTANCE: 15% of the human genome consists of endogenous retroviruses and other virus-derived elements inherited from ancestral viral infections. Many endogenous retroviruses from the HERV-K family retain the ability to proliferate across the genome and produce virus-like particles. Aberrant expression of the HERV-K envelope glycoprotein is associated with cancer, neurodegeneration, and autoimmune disease. Here, we report the crystal structure of the HERV-K envelope glycoprotein surface subunit. The structure provides a view in atomic-level detail of the molecular components in HERV-K most likely to trigger autoimmune responses. The structure also identifies binding sites for drug-like molecules, paving the way for future studies to develop new therapeutics.


  • Open Access

    Structure and methyl-lysine binding selectivity of the HUSH complex subunit MPP8

    by Nikos Nikolopoulos, Shun-Ichiro Oda, Daniil M. Prigozhin, Yorgo Modis

    The Human Silencing Hub (HUSH) guards the genome from the pathogenic effects of retroelement expression. Composed of MPP8, TASOR, and Periphilin-1, HUSH recognizes actively transcribed retrotransposed sequences by the presence of long (>1.5-kb) nascent transcripts without introns. HUSH recruits effectors that alter chromatin structure, degrade transcripts, and deposit transcriptionally repressive epigenetic marks. Here, we report the crystal structure of the C-terminal domain (CTD) of MPP8 necessary for HUSH activity. The MPP8 CTD consists of five ankyrin repeats followed by a domain with structural homology to the PINIT domains of Siz/PIAS-family SUMO E3 ligases. AlphaFold-Multimer modeling predicts that the MPP8 CTD forms extended interaction interfaces with a SPOC domain and a domain with a novel fold in TASOR. The MPP8 chromodomain, known to bind the repressive mark H3K9me3, binds with similar or higher affinity to sequences in the H3K9 methyltransferase subunits SETDB1, ATF7IP, G9a, and GLP. Hence, MPP8 promotes heterochromatinization by recruiting H3K9 methyltransferases. Our work identifies novel structural elements in MPP8 required for HUSH complex assembly and silencing, thereby fulfilling vital functions in controlling retrotransposons.